No internet connection — showing the saved version of the page.

Baxter Internatio…

USUSD
← to the screener

Baxter International Inc (LSE:0QK8) — Medical/Dental Instruments. Number of exchanges where the company shares trade: 5. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
baxter.com
Investor relations
investor.baxter.com/
Sector
Health Care · Medical/Dental Instruments
Headquarters
Deerfield, United States
Management
Steven P. Wallace
  • John Rogers · Executive Vice President and Chief Financial Officer
  • James Borzi · Executive Vice President, Chief Supply Chain Officer
  • James Teaff · President, Care & Connectivity Solutions
  • Julie Foster · President, Front Line Care
  • Scott Kaplan · Senior Vice President, Quality, Regulatory & Patient Safety
  • Adriana Guiry · Senior Vice President, Baxter Growth & Performance System
  • Piero Novello · Senior Vice President and President, International
  • Steve Wallace · President, Advanced Surgery & Commercial Excellence
  • Cecilia Soriano · Group President, Infusion Therapies and Platforms
  • David S. Rosenbloom · Executive Vice President and General Counsel
Latest reports
quarterly 2026 · 10-Q for the period ended 2026-03-31
Employees
61 500
Founded
1931
IPO
1961-05-15
Shares outstanding
517.35 M as of 2026-10-22
DateSharesChange
22.10.2026517.35 M+0.07%no significant change
23.07.2026517 M
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Free float
514.41 M
Market cap
13.07 B USD
Insiders
0.34%
Institutions
110.22%
Industry (SIC)
Surgical & Medical Instruments & Apparatus
Legal form
XTIQ
ISIN
US0718131099
LEI
J5OIVXX3P24RJRW5CK77
P/E
11.3
P/B
1.93
Payout ratio
loss
FCF
1.16 B USD
Payout / FCF
9%
Debt
844 M USD
net cash
Dividend streak
44 y
Earnings, FCF and dividends paid — for the 12 months to 30.09.2026 (the company's latest report).
Net income
−723 M USD 12 mo.
For the 12 months to 30.09.2026 (4 quarters)
Revenue11.6 B USD
− Expenses11.8 B USD
Gross profit3.49 B USD
Net income−723 M USD
History by quarter
RevenueExpensesLoss
31.12.2023: Revenue 2.73 B · Expenses 2.48 B · Operating profit 246 M · Net income 245 M31.03.2024: Revenue 2.49 B · Expenses 2.38 B · Operating profit 115 M · Net income 37.0 M30.06.2024: Revenue 2.69 B · Expenses 2.52 B · Operating profit 179 M · Net income −314 M30.09.2024: Revenue 2.70 B · Expenses 2.54 B · Operating profit 155 M · Net income 140 M31.12.2024: Revenue 2.75 B · Expenses 3.26 B · Operating profit −510 M · Net income −512 M31.03.2025: Revenue 2.63 B · Expenses 2.57 B · Operating profit 58.0 M · Net income 126 M30.06.2025: Revenue 2.81 B · Expenses 2.62 B · Operating profit 191 M · Net income 91.0 M30.09.2025: Revenue 2.84 B · Expenses 2.66 B · Operating profit 172 M · Net income −46.0 M31.12.2025: Revenue 2.97 B · Expenses 3.70 B · Operating profit −729 M · Net income −1.13 B31.03.2026: Revenue 2.70 B · Expenses 2.64 B · Operating profit 66.0 M · Net income −15.0 M30.06.2026: Revenue 2.96 B · Expenses 2.74 B · Operating profit 217 M · Net income 126 M30.09.2026: Revenue 2.98 B · Expenses 2.75 B · Operating profit 225 M · Net income 294 M
12.202309.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
12.57 USD · P/NAV 1.88
Balance sheet date30.09.2026
Assets19.4 B USD
− Liabilities12.9 B USD
= Total equity6.48 B USD
− Non-controlling interests−27.0 M USD
= NAV (equity of the company's shareholders)6.50 B USD
− Goodwill4.87 B USD
− Intangible assets3.93 B USD
= Tangible NAV−2.30 B USD
Shares517 348 188
NAV per share12.57 USD
Tangible NAV per share−4.44 USD
Share price (0QK8)23.5700 USD
P/NAV1.88
NAV history
Balance sheet dateNAVNAV per share
30.09.20266.50 B USD12.57 USD
30.06.20266.21 B USD12.00 USD
31.03.20266.04 B USD11.70 USD
31.12.20256.13 B USD11.91 USD
30.09.20257.24 B USD14.09 USD
30.06.20257.32 B USD14.25 USD
31.03.20257.08 B USD13.80 USD
31.12.20246.96 B USD13.61 USD
Description

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
common stock
US USA StocksBAX primaryUSD25.49 +5.24%common stock
LSE London Stock Exchange0QK8 IOBUSD23.57 +0.00%common stock
MI Borsa Italiana (Milan)1BAX secondaryEUR22.53 -1.10%common stock
MX Mexican Stock ExchangeBAX secondaryMXN471.88 +0.00%common stock
VI Vienna Stock ExchangeBAX secondaryEUR20.25 -5.77%common stock
depositary receipt
SA B3 Sao PauloB1AX34BRL61.1 +0.00%depositary receipt

Price

Hover / tap a day — open, close, high and low prices

Dividends

Next ex-date: 2026-11-27 · 0.01 USD (US:BAX)
Per year, US:BAX: 0.04 USD (4 paym.)

Baxter International Inc (BAX) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 0.04 USD per share (payments: 4). That is about 0.16% of the current share price. The next ex-dividend date is 27.11.2026: 0.01 USD per share, paid on 04.01.2027. Uninterrupted dividend history: 44 years.

Ordinary shares

Ex-datePaymentAmount%TypeTicker
2026-11-27 announced2027-01-040.0100 USD0.0/0.2 %quarterlyUS:BAX
2026-08-282026-10-010.0100 USD0.0/0.2 %quarterlyUS:BAX
2026-05-292026-07-010.0100 USD0.1/1.0 %quarterlyUS:BAX
2026-02-272026-04-010.0100 USD0.0/1.8 %quarterlyUS:BAX
2025-11-282026-01-020.0100 USD0.1/2.7 %quarterlyUS:BAX
2025-08-292025-10-010.1700 USD0.7/2.8 %quarterlyUS:BAX
2025-05-302025-07-010.1700 USD0.6/2.6 %quarterlyUS:BAX
2025-02-282025-04-010.1700 USD0.5/2.6 %quarterlyUS:BAX
2024-11-292025-01-020.1700 USD0.5/3.1 %quarterlyUS:BAX
2024-08-302024-10-010.2900 USD1.1/4.6 %quarterlyUS:BAX
2024-05-312024-07-010.2900 USD1.1/≈4.6 %quarterlyUS:BAX
2024-02-292024-04-010.2900 USD1.1/≈4.6 %quarterlyUS:BAX
2023-11-302024-01-020.2900 USD1.1/≈4.6 %quarterlyUS:BAX

Depositary receipts

Ex-datePaymentAmount%TypeTicker
2026-08-27—0.017759 BRL0.0/0.6 %regularSA:B1AX34
2026-05-28—0.018185 BRL0.0/1.1 %regularSA:B1AX34
2026-02-26—0.018054 BRL0.0/1.7 %regularSA:B1AX34
2025-11-27—0.019017 BRL0.0/2.2 %regularSA:B1AX34
2025-08-28—0.318053 BRL0.5/3.1 %regularSA:B1AX34
2025-05-29—0.324318 BRL0.5/2.6 %regularSA:B1AX34
2025-02-27—0.338624 BRL0.6/3.8 %regularSA:B1AX34
2024-11-28—0.366169 BRL0.6/4.1 %regularSA:B1AX34
2024-08-29—0.551319 BRL0.9/4.3 %regularSA:B1AX34
2024-05-29—0.575074 BRL0.9/4.6 %regularSA:B1AX34
2024-02-29—0.512193 BRL0.8/3.7 %regularSA:B1AX34
2023-11-30—0.494122 BRL0.8/5.3 %regularSA:B1AX34
2023-08-31—0.518411 BRL0.8/5.8 %regularSA:B1AX34
2023-06-01—0.725102 BRL1.2/6.2 %regularSA:B1AX34
2023-02-23—0.735962 BRL1.2/6.1 %regularSA:B1AX34
2022-12-01—0.789569 BRL1.3/6.1 %regularSA:B1AX34
2022-09-01—0.745373 BRL1.2/≈4.9 %regularSA:B1AX34
2022-06-02—0.781449 BRL1.3/≈3.6 %regularSA:B1AX34
2022-02-24—0.64638 BRL1.1/≈2.4 %regularSA:B1AX34
2021-12-02—0.79478 BRL1.3/≈1.3 %regularSA:B1AX34

News this week

Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.

Top holders

HolderStakeSharesReport date
Blackrock Inc.15.83%81.84 M2026-06-30
Pzena Investment Managem…12.63%65.3 M2026-06-30
Dodge & Cox Inc.11.29%58.39 M2026-06-30
FMR, LLC10.43%53.91 M2026-06-30
Dodge & Cox Funds-Dodge…7.47%38.62 M2026-06-30
Vanguard Capital Managem…6.53%33.75 M2026-06-30
Vanguard Portfolio Manag…4.65%24.06 M2026-06-30
State Street Corporation3.98%20.6 M2026-06-30
BLACKROCK EQUITY DIVIDEN…3.67%18.97 M2026-07-31
VANGUARD INDEX FUNDS-Van…3.17%16.4 M2026-06-30
Greenhaven Associates, I…2.76%14.29 M2026-06-30
Geode Capital Management…2.73%14.12 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.38 M2026-06-30
Invesco Ltd.2.39%12.36 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%11.83 M2026-06-30
VANGUARD WINDSOR FUNDS-V…2.02%10.44 M2026-04-30
Invesco Exchange-Traded…1.8%9.31 M2026-08-31
Fidelity Hastings Street…1.74%8.97 M2026-07-31
VANGUARD INDEX FUNDS-Van…1.45%7.5 M2026-06-30
Fidelity Rutland Square…1.38%7.15 M2026-07-31
HIDER ANDREW P (Chief Ex…≈0.11%572 2392026-02-27
GRADE JOEL T. (Chief Fin…≈0.05%279 8282026-02-27
MASON JEANNE K (Officer)≈0.04%199 6592025-03-06
KNIGHT HEATHER (Chief Op…≈0.03%177 3622025-03-06
ROSENBLOOM DAVID S (Gene…≈0.03%144 8372026-02-27
RASUL REAZUR (Officer)≈0.03%139 8462026-02-09
SONIG ALOK (Officer)≈0.03%130 2982025-03-06
SORIANO MARIA CECILIA (O…≈0.02%77 8942026-02-27
BORZI JAMES W (Officer)≈0.01%73 1342025-03-06
SHAFER DAVID BRENT (Chai…≈0.01%72 8042026-05-05